These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2152811)

  • 1. Conditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA.
    Kirkegaard K; Nelsen B
    J Virol; 1990 Jan; 64(1):185-94. PubMed ID: 2152811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.
    Kirkegaard K
    J Virol; 1990 Jan; 64(1):195-206. PubMed ID: 2152812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
    Couderc T; Hogle J; Le Blay H; Horaud F; Blondel B
    J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome.
    Iizuka N; Kohara M; Hagino-Yamagishi K; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1989 Dec; 63(12):5354-63. PubMed ID: 2555560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.
    Lu HH; Yang CF; Murdin AD; Klein MH; Harber JJ; Kew OM; Wimmer E
    J Virol; 1994 Nov; 68(11):7507-15. PubMed ID: 7933134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
    La Monica N; Meriam C; Racaniello VR
    J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.
    Blair WS; Semler BL
    J Virol; 1991 Nov; 65(11):6111-23. PubMed ID: 1656088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5' noncoding region.
    Andino R; Rieckhof GE; Trono D; Baltimore D
    J Virol; 1990 Feb; 64(2):607-12. PubMed ID: 2153227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant poliovirus containing a novel proteolytic cleavage site in VP3 is altered in viral maturation.
    Blair WS; Hwang SS; Ypma-Wong MF; Semler BL
    J Virol; 1990 Apr; 64(4):1784-93. PubMed ID: 2157059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors.
    Liao S; Racaniello V
    J Virol; 1997 Dec; 71(12):9770-7. PubMed ID: 9371643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1.
    van der Werf S; Wychowski C; Bruneau P; Blondel B; Crainic R; Horodniceanu F; Girard M
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5080-4. PubMed ID: 6308670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis.
    Diamond SE; Kirkegaard K
    J Virol; 1994 Feb; 68(2):863-76. PubMed ID: 8289389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro construction of poliovirus defective interfering particles.
    Hagino-Yamagishi K; Nomoto A
    J Virol; 1989 Dec; 63(12):5386-92. PubMed ID: 2555563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An RNA hairpin at the extreme 5' end of the poliovirus RNA genome modulates viral translation in human cells.
    Simoes EA; Sarnow P
    J Virol; 1991 Feb; 65(2):913-21. PubMed ID: 1846205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simian virus 40 host range/helper function mutations cause multiple defects in viral late gene expression.
    Stacy T; Chamberlain M; Cole CN
    J Virol; 1989 Dec; 63(12):5208-15. PubMed ID: 2555552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations which alter the level or structure of nsP4 can affect the efficiency of Sindbis virus replication in a host-dependent manner.
    Lemm JA; Durbin RK; Stollar V; Rice CM
    J Virol; 1990 Jun; 64(6):3001-11. PubMed ID: 2159558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
    Kohara M; Omata T; Kameda A; Semler BL; Itoh H; Wimmer E; Nomoto A
    J Virol; 1985 Mar; 53(3):786-92. PubMed ID: 2983090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.